AI in biopharma:
no longer theoretical
The question is no longer whether AI can change biopharma. It already is. Pharma giants are reshaping their workforces, the first AI-designed drugs are making their way through the clinic, and record money is meeting rising doubt about the payoff.
AI Day returns in 2026 for the next question: what changes for the people building the future of medicine?
It brings together leaders across biopharma, academia, the frontier labs and venture capital, hosted by Endpoints senior biopharma correspondent Andrew Dunn. Take part two ways: an exclusive in-person experience in New York City or a free virtual-only program.
Agenda at a Glance
Morning sessions
- 11:00 AM - 2:00 PM ET Virtual programming
- virtual
Join us online for a fast-paced editorial briefing hosted by Endpoints journalists. We'll dig into what AI is actually upending in biopharma, from stunning progress in designing proteins on the computer to visions of ushering in a new era of personalized medicine.
Afternoon sessions
- 3:00 PM - 4:00 PM ETArrival & welcome drinks
- 4:00 PM - 6:00 PM ETEditorial sessions
- 6:00 PM - 8:00 PM ETHappy hour & networking
The conversation shifts to Manhattan for exclusive, live editorial sessions that bring together the AI and biopharma worlds. Endpoints’ Andrew Dunn will lead candid conversations with those industries’ most influential voices, with topics ranging from pharma’s cultural remaking to managing biosecurity concerns to the future role of the human scientist.
Afternoon programming will be followed by a networking reception with an open bar and heavy hors d’oeuvres.
SPEAKERS
Christine Parthemore
Head of Biodefense
Radical Numerics
Eric Nguyen
Co-Founder & CEO
Radical Numerics
Sergey Edunov
CTO
Genesis Molecular AI
Zavain Dar
Founder & Managing Partner
Dimension
Kyunghyun Cho
Glen de Vries Professor of Health Statistics, Professor of Computer Science & Data Science
Courant Institute of Mathematical Sciences, NYU
Nathan Frey
Head of Drug Discovery & Development Research
Anthropic
Najat Khan
CEO & President
Recursion
David Baker
Professor, Biochemistry; Director, Institute for Protein Design
University of Washington - HHMI Investigator
John Finn
CSO
Basecamp Research
Travis Zack
Chief Medical Officer
OpenEvidence, Inc.
Subbu Iyer
Head, AI & Data
Takeda
Sydney Klein
SVP, Chief Information Security Officer & Head of Enterprise IT
Bristol Myers Squibb
Andrew Dunn
Senior Biopharma Correspondent
Endpoints News
Moderator
Ngai Yeung
Reporter
Endpoints
Moderator
Ryan Cross
Senior Science Correspondent
Endpoints News
Moderator
Stay tuned for additional speakers to be announced.
Select your pass
Join the virtual conversation, or get the All Access pass to also join us live in NYC for the afternoon programming and evening happy hour. Part of the afternoon is livestreamed to everyone. The exclusive sessions happen in person only.
- Morning virtual programming, live and on-demand
- Select afternoon sessions, livestreamed
- On-demand recordings of all streamed programming
- Not included: exclusive in-person-only sessions
live afternoon in NYC +
happy hour
- Curated room of senior leaders and AI researchers
- Virtual programming
- Exclusive in-person-only sessions and facilitated discussions, not streamed or recorded
- Networking reception with open bar and heavy hors d'oeuvres
- On-demand access to all streamed programming
Need financial assistance? Contact alorch@endpoints.news to apply for a reduced ticket fee.
Venue
The Georgia Room
We return to the Georgia Room, an art deco gathering space in the heart of Manhattan. This year the event has the full floor, with more room for conversations and networking.
Join us on site for the afternoon programming with the Endpoints editorial team, followed by a networking reception with an open bar and heavy hors d'oeuvres.




